Cortistatin exerts an immunomodulatory and neuroprotective role in a preclinical model of ischemic stroke
Julia Castillo-GonzáleziD, Lara BuscemiiD, Pablo Vargas-RodrígueziD, Ignacio Serrano-MartíneziD, Irene Forte‐LagoiD, Marta CaroiD, M. Price, Pedro Hernández‐CortésiD, Lorenz HirtiD, Elena González‐ReyiD
Abstract
Ischemic stroke is the result of a permanent or transient occlusion of a brain artery, leading to irreversible tissue injury and long-term sequelae. Despite ongoing advancements in revascularization techniques, stroke remains the second leading cause of death worldwide. A comprehensive understanding of the complex and interconnected mechanisms, along with the endogenous mediators that modulate stroke responses is essential for the development of effective interventions. Our study investigates cortistatin, a neuropeptide extensively distributed in the immune and central nervous systems, known for its immunomodulatory properties. With neuroinflammation and peripheral immune deregulation as key pathological features of brain ischemia, cortistatin emerges as a promising therapeutic candidate. To this aim, we evaluated its potential effect in a well-established middle cerebral artery occlusion (MCAO) preclinical stroke model. Our findings indicate that the peripheral administration of cortistatin at 24 hours post-stroke significantly reduces neurological damage and enhances recovery. Importantly, cortistatin-induced neuroprotection was multitargeted, as it modulated the glial reactivity and astrocytic scar formation, facilitated blood-brain barrier recovery, and regulated local and systemic immune dysfunction. Surprisingly, administration of cortistatin at immediate and early post-stroke time points proved to be not beneficial and even detrimental. These results emphasize the importance of understanding the spatio-temporal dynamics of stroke pathology to develop innovative therapeutic strategies. Premature interruption of certain neuroinflammatory processes might inadvertently compromise neuroprotective mechanisms. In summary, our study highlights cortistatin as a novel pleiotropic therapeutic approach against ischemic stroke, offering new treatment options for patients for whom early revascularization intervention is unsuccessful. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=100 SRC="FIGDIR/small/579281v3_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@b20a6dorg.highwire.dtl.DTLVardef@cab2e1org.highwire.dtl.DTLVardef@1a6088dorg.highwire.dtl.DTLVardef@17b723d_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 1.23
- Field percentile
- top 25%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lack of cortistatin drives neuroimmune and vascular dysfunction in brain ischemia
Julia Castillo-González, Pablo Vargas-Rodríguez, … Elena González‐Rey·Journal of Biomedical SciencePeer-reviewed·Jun 20, 2026
- Continuous administration of the p38α inhibitor neflamapimod during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level
J. J. Alam, M. Krakovsky, … A. Levy·bioRxiv·Apr 29, 2020
- Neuronal and Astrocyte Insulin-like Growth Factor-1 Signaling Differentially Modulates Ischemic Stroke Damage
Cellas A. Hayes, Nyah I. Morgan, … Nicole M. Ashpole·bioRxiv·Apr 2, 2023
- Early Intervention with Electrical Stimulation Reduces Neural Damage After Stroke in Non-human Primates
Jasmine Zhou, Karam Khateeb, Azadeh Yazdan-Shahmorad·Nature CommunicationsPeer-reviewed·Jul 21, 2025
- The nuclear receptor NR4A1 serves as a neutrophil-intrinsic regulator mitigating stroke severity
Jan‐Kolja Strecker, Yannick Schmidt, … Jens Minnerup·bioRxiv·Sep 19, 2025
- Once delayed non-invasive remote ischemic preconditioning protects against early stroke by modulating neuroinflammatory responses in rats
Xiangnan Du, Jian Yang, … Xiaokun Geng·bioRxiv·May 14, 2020